Structural basis of a public antibody response to SARS-CoV-2

Molecular-level understanding of human neutralizing antibody responses to SARS-CoV-2 could accelerate vaccine design and facilitate drug discovery. We analyzed 294 SARS-CoV-2 antibodies and found that IGHV3–53 is the most frequently used IGHV gene for targeting the receptor binding domain (RBD) of t...

詳細記述

保存先:
書誌詳細
出版年:bioRxiv
主要な著者: Yuan, Meng, Liu, Hejun, Wu, Nicholas C., Lee, Chang-Chun D., Zhu, Xueyong, Zhao, Fangzhu, Huang, Deli, Yu, Wenli, Hua, Yuanzi, Tien, Henry, Rogers, Thomas F., Landais, Elise, Sok, Devin, Jardine, Joseph G., Burton, Dennis R., Wilson, Ian A.
フォーマット: Artigo
言語:Inglês
出版事項: Cold Spring Harbor Laboratory 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302194/
https://ncbi.nlm.nih.gov/pubmed/32577642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.06.08.141267
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料